COVID-19 Turkey Web Portal

COVID-19 in Turkey

Here you can access the most up-to-date and reliable information about the course of COVID -19 cases in Turkey. The following numbers are updated periodically, only according to information supplied by the Ministry of Health of The Republic of Turkey authorized personnel.

1809809

Number of cases

16199

Number of death

1581565

Number of recovery

Last update: 13/12/2020 18:55:27

Situation in the World

 

Scientific Resources

Articles, Datasets, Useful Links

 
ALO184

Coronavirus (COVID-19) Hotline

Alo 184

 
Online Corona Test

Would you like to check for "coronavirus" online?

Announcements

Current news and developments on COVID-19 are included here

A Book by TUBITAK Explaining Coronavirus to Children
A Book by TUBITAK Explaining Coronavirus to Children

21.08.2020

President Erdoğan, came together with COVID-19 Turkey Platform Members
President Erdoğan, came together with COVID-19 Turkey Platform Members

13.08.2020

Evaluation Results of Projects Submitted to Development Agencies within the Scope of Struggling COVID-19 Calls
Evaluation Results of Projects Submitted to Development Agencies within the Scope of Struggling COVID-19 Calls

13.07.2020

TÜBİTAK President Prof. Dr. Hasan Mandal met STAR scholarship holders
TÜBİTAK President Prof. Dr. Hasan Mandal met STAR scholarship holders

26.06.2020

Minister Varank and President Mandal Examined Vaccine and Drug Development Studies On Site
Minister Varank and President Mandal Examined Vaccine and Drug Development Studies On Site

26.06.2020

Covid-19 Collaboration Webinar Held Under the Roof of the Center of Excellence
Covid-19 Collaboration Webinar Held Under the Roof of the Center of Excellence

26.06.2020

Domestic drug has been developed with the support of TUBITAK
Domestic drug has been developed with the support of TUBITAK

13.06.2020

COVID-19 Turkey Platform Monthly Assessment Meeting Held
COVID-19 Turkey Platform Monthly Assessment Meeting Held

12.06.2020

All

Most Recently Added

The most up-to-date academic additions are included in this section

İlaçların yeni hedefe yönlendirilmesi ve COVID-19 inhibitörü belirlenmesi çalışması Prof. Dr. Serdar Durdağı, Bahçeşehir Üniversitesi
The study of directing drugs to the new target and determining the COVID-19 inhibitor (Prof. Dr. Serdar Durdağı, Bahçeşehir University)
Klinik aşaması belirtilmiş tedavi ve aşı adayları gelişmeleri Milken Institute
Clinical stage specified treatment and vaccine candidate developments Milken Institute
Akciğer görüntülerinin derin öğrenme ile karşılaştırılması. Fatıma Rabia Yapıcıoğlu
Comparison of lung images with deep learning (Fatıma Rabia Yapıcıoğlu)
Dr. Özge Fındık Şener
Comparison of cases of patients whose swab results were positive for COVID (Dr. Özge Fındık Şener, Üniversita di Pavia)
COVID19 salgınına neden olan SARS-CoV ve SARS-CoV-2 ACE2 reseptörünün yapısı
Evidence-based evaluation of active ingredients for COVID-19 treatments
COVID-19 açık erişimli makaleler için yenilikçi arama motoru geliştirildi!
Innovative search engine has been developed for COVID-19 open access articles!
Bilimsel Kaynaklar
Current developments and new scientific resources on COVID-19 are added
Bilimsel Araştırma Paylaşım Platformuna yeni katkılar ekleniyor
New contributions are added to the Scientific Research Sharing Platform
SARS-CoV-2 Arayüzü
To support analysis of virus spread SARS-CoV-2 Epidemiology Interface was developed
Inhibitor Determination and Clinical Studies

The most up-to-date inhibitor identification studies and clinical research developments worldwide against COVID-19 are provided here and updated daily

Lopinavir
Lopinavir

Protease inhibitor, anti-HIV approved

Emtricitabine
Emtricitabine

Nucleoside reverse transcriptase inhibitor, anti-HIV approved, anti-HBV

Ritonavir
Ritonavir

Protease inhibitor, anti-HIV approved

Methylprednisolone
Methylprednisolone

nCoV Phase II, approved for allergic asthma and rheumatic diseases

ALL